1
|
Crocco P, De Rango F, Bruno F, Malvaso A, Maletta R, Bruni AC, Passarino G, Rose G, Dato S. Genetic variability of FOXP2 and its targets CNTNAP2 and PRNP in frontotemporal dementia: A pilot study in a southern Italian population. Heliyon 2024; 10:e31624. [PMID: 38828303 PMCID: PMC11140708 DOI: 10.1016/j.heliyon.2024.e31624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2024] [Revised: 05/17/2024] [Accepted: 05/20/2024] [Indexed: 06/05/2024] Open
Abstract
The Forkhead box P2 (FOXP2) is an evolutionary conserved transcription factor involved in the maintenance of neuronal networks, implicated in language disorders. Some evidence suggests a possible link between FOXP2 genetic variability and frontotemporal dementia (FTD) pathology and related endophenotypes. To shed light on this issue, we analysed the association between single-nucleotide polymorphisms (SNPs) in FOXP2 and FTD in 113 patients and 223 healthy controls. In addition, we investigated SNPs in two putative targets of FOXP2, CNTNAP2, Contactin-associated protein-like 2 and PRNP, prion protein genes. Overall, 27 SNPs were selected by a tagging approach. FOXP2-rs17213159-C/T resulted associated with disease risk (OR = 2.16, P = 0.0004), as well as with age at onset and severity of dementia. Other FOXP2 markers were associated with semantic and phonological fluency scores, cognitive levels (MMSE) and neuropsychological tests. Associations with language, cognitive and brain atrophy measures were found with CNTNAP2 and PRNP genetic variability. Overall, although preliminary, results here presented suggest an influence of regulatory pathways centred on FOXP2 as a molecular background of FTD affecting neurological function of multiple brain areas.
Collapse
Affiliation(s)
- Paolina Crocco
- Department of Biology, Ecology and Earth Sciences, University of Calabria, Rende, Italy
| | - Francesco De Rango
- Department of Biology, Ecology and Earth Sciences, University of Calabria, Rende, Italy
| | - Francesco Bruno
- Regional Neurogenetic Centre, ASP Catanzaro, Lamezia Terme, Italy
| | - Antonio Malvaso
- IRCCS Mondino Foundation – National Neurological Institute, Department of Brain and Behavioral Sciences, University of Pavia, Italy
| | - Raffaele Maletta
- Regional Neurogenetic Centre, ASP Catanzaro, Lamezia Terme, Italy
| | - Amalia C. Bruni
- Regional Neurogenetic Centre, ASP Catanzaro, Lamezia Terme, Italy
| | - Giuseppe Passarino
- Department of Biology, Ecology and Earth Sciences, University of Calabria, Rende, Italy
| | - Giuseppina Rose
- Department of Biology, Ecology and Earth Sciences, University of Calabria, Rende, Italy
| | - Serena Dato
- Department of Biology, Ecology and Earth Sciences, University of Calabria, Rende, Italy
| |
Collapse
|
2
|
García AM, de Leon J, Tee BL, Blasi DE, Gorno-Tempini ML. Speech and language markers of neurodegeneration: a call for global equity. Brain 2023; 146:4870-4879. [PMID: 37497623 PMCID: PMC10690018 DOI: 10.1093/brain/awad253] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Revised: 06/29/2023] [Accepted: 07/15/2023] [Indexed: 07/28/2023] Open
Abstract
In the field of neurodegeneration, speech and language assessments are useful for diagnosing aphasic syndromes and for characterizing other disorders. As a complement to classic tests, scalable and low-cost digital tools can capture relevant anomalies automatically, potentially supporting the quest for globally equitable markers of brain health. However, this promise remains unfulfilled due to limited linguistic diversity in scientific works and clinical instruments. Here we argue for cross-linguistic research as a core strategy to counter this problem. First, we survey the contributions of linguistic assessments in the study of primary progressive aphasia and the three most prevalent neurodegenerative disorders worldwide-Alzheimer's disease, Parkinson's disease, and behavioural variant frontotemporal dementia. Second, we address two forms of linguistic unfairness in the literature: the neglect of most of the world's 7000 languages and the preponderance of English-speaking cohorts. Third, we review studies showing that linguistic dysfunctions in a given disorder may vary depending on the patient's language and that English speakers offer a suboptimal benchmark for other language groups. Finally, we highlight different approaches, tools and initiatives for cross-linguistic research, identifying core challenges for their deployment. Overall, we seek to inspire timely actions to counter a looming source of inequity in behavioural neurology.
Collapse
Affiliation(s)
- Adolfo M García
- Global Brain Health Institute, University of California, San Francisco, CA 94143, USA
- Cognitive Neuroscience Center, Universidad de San Andrés, Buenos Aires B1644BID, Argentina
- Departamento de Lingüística y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, Santiago 9160000, Chile
- Latin American Brain Health (BrainLat) Institute, Universidad Adolfo Ibáñez, Avenida Diagonal Las Torres 2640 (7941169), Santiago, Peñalolén, Región Metropolitana, Chile
| | - Jessica de Leon
- Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA 94143, USA
| | - Boon Lead Tee
- Global Brain Health Institute, University of California, San Francisco, CA 94143, USA
- Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA 94143, USA
| | - Damián E Blasi
- Data Science Initiative, Harvard University, Cambridge, MA 02138, USA
- Department of Human Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA
- Department of Linguistic and Cultural Evolution, Max Planck Institute for the Science of Human History, Jena 07745, Germany
| | - Maria Luisa Gorno-Tempini
- Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA 94143, USA
| |
Collapse
|
3
|
Cabrera-Martín MN, Nespral P, Valles-Salgado M, Bascuñana P, Delgado-Alonso C, Delgado-Álvarez A, Fernández-Romero L, López-Carbonero JI, Díez-Cirarda M, Gil-Moreno MJ, Matías-Guiu J, Matias-Guiu JA. FDG-PET-based neural correlates of Addenbrooke's cognitive examination III scores in Alzheimer's disease and frontotemporal degeneration. Front Psychol 2023; 14:1273608. [PMID: 38034292 PMCID: PMC10687370 DOI: 10.3389/fpsyg.2023.1273608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2023] [Accepted: 11/02/2023] [Indexed: 12/02/2023] Open
Abstract
Introduction The Addenbrooke's Cognitive Examination III (ACE-III) is a brief test useful for neuropsychological assessment. Several studies have validated the test for the diagnosis of Alzheimer's disease (AD) and frontotemporal dementia (FTD). In this study, we aimed to examine the metabolic correlates associated with the performance of ACE-III in AD and behavioral variant FTD. Methods We enrolled 300 participants in a cross-sectional study, including 180 patients with AD, 60 with behavioral FTD (bvFTD), and 60 controls. An 18F-Fluorodeoxyglucose positron emission tomography study was performed in all cases. Correlation between the ACE-III and its domains (attention, memory, fluency, language, and visuospatial) with the brain metabolism was estimated. Results The ACE-III showed distinct neural correlates in bvFTD and AD, effectively capturing the most relevant regions involved in these disorders. Neural correlates differed for each domain, especially in the case of bvFTD. Lower ACE-III scores were associated with more advanced stages in both disorders. The ACE-III exhibited high discrimination between bvFTD vs. HC, and between AD vs. HC. Additionally, it was sensitive to detect hypometabolism in brain regions associated with bvFTD and AD. Conclusion Our study contributes to the knowledge of the brain regions associated with ACE-III, thereby facilitating its interpretation, and highlighting its suitability for screening and monitoring. This study provides further validation of ACE-III in the context of AD and FTD.
Collapse
Affiliation(s)
- María Nieves Cabrera-Martín
- Department of Neurology, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - Pedro Nespral
- Department of Neurology, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - Maria Valles-Salgado
- Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - Pablo Bascuñana
- Department of Neurology, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - Cristina Delgado-Alonso
- Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - Alfonso Delgado-Álvarez
- Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - Lucía Fernández-Romero
- Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - Juan Ignacio López-Carbonero
- Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - María Díez-Cirarda
- Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - María José Gil-Moreno
- Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - Jorge Matías-Guiu
- Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| | - Jordi A. Matias-Guiu
- Department of Nuclear Medicine, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Madrid, Spain
| |
Collapse
|
4
|
Díaz-Rivera MN, Birba A, Fittipaldi S, Mola D, Morera Y, de Vega M, Moguilner S, Lillo P, Slachevsky A, González Campo C, Ibáñez A, García AM. Multidimensional inhibitory signatures of sentential negation in behavioral variant frontotemporal dementia. Cereb Cortex 2022; 33:403-420. [PMID: 35253864 PMCID: PMC9837611 DOI: 10.1093/cercor/bhac074] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Revised: 01/31/2022] [Accepted: 02/07/2022] [Indexed: 01/19/2023] Open
Abstract
BACKGROUND Processing of linguistic negation has been associated to inhibitory brain mechanisms. However, no study has tapped this link via multimodal measures in patients with core inhibitory alterations, a critical approach to reveal direct neural correlates and potential disease markers. METHODS Here we examined oscillatory, neuroanatomical, and functional connectivity signatures of a recently reported Go/No-go negation task in healthy controls and behavioral variant frontotemporal dementia (bvFTD) patients, typified by primary and generalized inhibitory disruptions. To test for specificity, we also recruited persons with Alzheimer's disease (AD), a disease involving frequent but nonprimary inhibitory deficits. RESULTS In controls, negative sentences in the No-go condition distinctly involved frontocentral delta (2-3 Hz) suppression, a canonical inhibitory marker. In bvFTD patients, this modulation was selectively abolished and significantly correlated with the volume and functional connectivity of regions supporting inhibition (e.g. precentral gyrus, caudate nucleus, and cerebellum). Such canonical delta suppression was preserved in the AD group and associated with widespread anatomo-functional patterns across non-inhibitory regions. DISCUSSION These findings suggest that negation hinges on the integrity and interaction of spatiotemporal inhibitory mechanisms. Moreover, our results reveal potential neurocognitive markers of bvFTD, opening a new agenda at the crossing of cognitive neuroscience and behavioral neurology.
Collapse
Affiliation(s)
- Mariano N Díaz-Rivera
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, Vito Dumas 284, Buenos Aires B1644BID, Argentina.,Agencia Nacional de Promoción Científica y Tecnológica (ANPCyT), C1425FQD, Godoy Cruz 2370, Buenos Aires, Argentina
| | - Agustina Birba
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, Vito Dumas 284, Buenos Aires B1644BID, Argentina.,National Scientific and Technical Research Council (CONICET), C1425FQD, Godoy Cruz 2290, Buenos Aires, Argentina
| | - Sol Fittipaldi
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, Vito Dumas 284, Buenos Aires B1644BID, Argentina.,National Scientific and Technical Research Council (CONICET), C1425FQD, Godoy Cruz 2290, Buenos Aires, Argentina
| | - Débora Mola
- Instituto de Investigaciones Psicológicas, CONICET, 5000, Universidad Nacional de Córdoba, Córdoba, Argentina
| | - Yurena Morera
- Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, Campus de Guajara, 38205 La Laguna, Santa Cruz de Tenerife, Spain
| | - Manuel de Vega
- Instituto Universitario de Neurociencia (IUNE), Universidad de La Laguna, Campus de Guajara, 38205 La Laguna, Santa Cruz de Tenerife, Spain
| | - Sebastian Moguilner
- Global Brain Health Institute, University of California, San Francisco, CA94158, US; and Trinity College, Dublin D02DP21, , Ireland.,Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, 8320000, Santiago, Chile
| | - Patricia Lillo
- Departamento de Neurología Sur, Facultad de Medicina, Universidad de Chile, 8380000, Santiago, Chile.,Unidad de Neurología, Hospital San José, 8380000, Santiago, Chile.,Geroscience Center for Brain Health and Metabolism (GERO), 7800003, Santiago, Chile
| | - Andrea Slachevsky
- Geroscience Center for Brain Health and Metabolism (GERO), 7800003, Santiago, Chile.,Neuropsychology and Clinical Neuroscience Laboratory (LANNEC), Physiopathology Department, Neuroscience and East Neuroscience Departments, Faculty of Medicine, Institute of Biomedical Sciences (ICBM), University of Chile, 8380000, Santiago, Chile.,Memory and Neuropsychiatric Clinic (CMYN) Neurology Department, Hospital del Salvador and Faculty of Medicine, University of Chile, 7500000, Santiago, Chile.,Departamento de Medicina, Servicio de Neurología, Clínica Alemana-Universidad del Desarrollo, 7550000, Santiago, Chile
| | - Cecilia González Campo
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, Vito Dumas 284, Buenos Aires B1644BID, Argentina.,National Scientific and Technical Research Council (CONICET), C1425FQD, Godoy Cruz 2290, Buenos Aires, Argentina
| | - Agustín Ibáñez
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, Vito Dumas 284, Buenos Aires B1644BID, Argentina.,National Scientific and Technical Research Council (CONICET), C1425FQD, Godoy Cruz 2290, Buenos Aires, Argentina.,Global Brain Health Institute, University of California, San Francisco, CA94158, US; and Trinity College, Dublin D02DP21, , Ireland.,Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, 8320000, Santiago, Chile
| | - Adolfo M García
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, Vito Dumas 284, Buenos Aires B1644BID, Argentina.,National Scientific and Technical Research Council (CONICET), C1425FQD, Godoy Cruz 2290, Buenos Aires, Argentina.,Global Brain Health Institute, University of California, San Francisco, CA94158, US; and Trinity College, Dublin D02DP21, , Ireland.,Departamento de Lingüística y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, 7550000, Santiago, Chile
| |
Collapse
|
5
|
Birba A, Fittipaldi S, Cediel Escobar JC, Gonzalez Campo C, Legaz A, Galiani A, Díaz Rivera MN, Martorell Caro M, Alifano F, Piña-Escudero SD, Cardona JF, Neely A, Forno G, Carpinella M, Slachevsky A, Serrano C, Sedeño L, Ibáñez A, García AM. Multimodal Neurocognitive Markers of Naturalistic Discourse Typify Diverse Neurodegenerative Diseases. Cereb Cortex 2022; 32:3377-3391. [PMID: 34875690 PMCID: PMC9376869 DOI: 10.1093/cercor/bhab421] [Citation(s) in RCA: 24] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2021] [Revised: 10/05/2021] [Accepted: 10/28/2021] [Indexed: 02/07/2023] Open
Abstract
Neurodegeneration has multiscalar impacts, including behavioral, neuroanatomical, and neurofunctional disruptions. Can disease-differential alterations be captured across such dimensions using naturalistic stimuli? To address this question, we assessed comprehension of four naturalistic stories, highlighting action, nonaction, social, and nonsocial events, in Parkinson's disease (PD) and behavioral variant frontotemporal dementia (bvFTD) relative to Alzheimer's disease patients and healthy controls. Text-specific correlates were evaluated via voxel-based morphometry, spatial (fMRI), and temporal (hd-EEG) functional connectivity. PD patients presented action-text deficits related to the volume of action-observation regions, connectivity across motor-related and multimodal-semantic hubs, and frontal hd-EEG hypoconnectivity. BvFTD patients exhibited social-text deficits, associated with atrophy and spatial connectivity patterns along social-network hubs, alongside right frontotemporal hd-EEG hypoconnectivity. Alzheimer's disease patients showed impairments in all stories, widespread atrophy and spatial connectivity patterns, and heightened occipitotemporal hd-EEG connectivity. Our framework revealed disease-specific signatures across behavioral, neuroanatomical, and neurofunctional dimensions, highlighting the sensitivity and specificity of a single naturalistic task. This investigation opens a translational agenda combining ecological approaches and multimodal cognitive neuroscience for the study of neurodegeneration.
Collapse
Affiliation(s)
- Agustina Birba
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, B1644BID Buenos Aires, Argentina
- National Scientific and Technical Research Council (CONICET), C1425FQD Buenos Aires, Argentina
| | - Sol Fittipaldi
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, B1644BID Buenos Aires, Argentina
- National Scientific and Technical Research Council (CONICET), C1425FQD Buenos Aires, Argentina
| | - Judith C Cediel Escobar
- Facultad de Psicología, Universidad del Valle, Santiago de Cali 76001, Colombia
- Departamento de Estudios Psicológicos, Facultad de Derecho y Ciencias Sociales, Universidad Icesi, Cali 1234567, Colombia
| | - Cecilia Gonzalez Campo
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, B1644BID Buenos Aires, Argentina
- National Scientific and Technical Research Council (CONICET), C1425FQD Buenos Aires, Argentina
| | - Agustina Legaz
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, B1644BID Buenos Aires, Argentina
- National Scientific and Technical Research Council (CONICET), C1425FQD Buenos Aires, Argentina
| | - Agostina Galiani
- Institute of Cognitive and Translational Neuroscience (INCyT), INECO Foundation, Favaloro University, CONICET, C1060AAF Buenos Aires, Argentina
| | - Mariano N Díaz Rivera
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, B1644BID Buenos Aires, Argentina
- National Agency of Scientific and Technological Promotion, C1425FQD Buenos Aires, Argentina
| | - Miquel Martorell Caro
- National Scientific and Technical Research Council (CONICET), C1425FQD Buenos Aires, Argentina
| | - Florencia Alifano
- National Scientific and Technical Research Council (CONICET), C1425FQD Buenos Aires, Argentina
| | | | - Juan Felipe Cardona
- Facultad de Psicología, Universidad del Valle, Santiago de Cali 76001, Colombia
| | - Alejandra Neely
- Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, 8320000 Santiago, Chile
| | - Gonzalo Forno
- Neuropsychology and Clinical Neuroscience Laboratory, Physiopathology Department, ICBM, Neurosciences Department, Faculty of Medicine, University of Chile, 8380000 Santiago, Chile
- School of Psychology, Universidad de los Andes, 7620001 Santiago, Chile
- Alzheimer's and other cognitive disorders group, Institute of Neurosciences, University of Barcelona, 8007 Barcelona, Spain
| | - Mariela Carpinella
- Unidad de Neurociencias, Instituto Conci Carpinella, 5000 Córdoba, Argentina
- Facultad de Medicina, Universidad Católica de Cuyo Sede San Luis, 5700 San Luis, Argentina
| | - Andrea Slachevsky
- Neuropsychology and Clinical Neuroscience Laboratory, Physiopathology Department, ICBM, Neurosciences Department, Faculty of Medicine, University of Chile, 8380000 Santiago, Chile
- Gerosciences Center for Brain Health and Metabolism, 7800003 Santiago, Chile
- Memory and Neuropsychiatric Clinic (CMYN) Neurology Department, Hospital del Salvador & University of Chile, 7500000 Santiago, Chile
- Servicio de Neurología, Departamento de Medicina, Clínica Alemana-Universidad del Desarrollo, 7690000 Santiago, Chile
| | - Cecilia Serrano
- Unidad de Neurología Cognitiva, Hospital César Milstein, C1221AC Buenos Aires, Argentina
| | - Lucas Sedeño
- National Scientific and Technical Research Council (CONICET), C1425FQD Buenos Aires, Argentina
| | - Agustín Ibáñez
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, B1644BID Buenos Aires, Argentina
- National Scientific and Technical Research Council (CONICET), C1425FQD Buenos Aires, Argentina
- Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, 8320000 Santiago, Chile
- Global Brain Health Institute, University of California, San Francisco, CA 94158, US; and Trinity College, Dublin D02 DP21, Ireland
| | - Adolfo M García
- Centro de Neurociencias Cognitivas, Universidad de San Andrés, B1644BID Buenos Aires, Argentina
- National Scientific and Technical Research Council (CONICET), C1425FQD Buenos Aires, Argentina
- Global Brain Health Institute, University of California, San Francisco, CA 94158, US; and Trinity College, Dublin D02 DP21, Ireland
- Departamento de Lingüística y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, 8431166 Santiago, Chile
| |
Collapse
|
6
|
Cerami C, Perdixi E, Meli C, Marcone A, Zamboni M, Iannaccone S, Dodich A. Early Identification of Different Behavioral Phenotypes in the Behavioral Variant of Frontotemporal Dementia with the Aid of the Mini-Frontal Behavioral Inventory (mini-FBI). J Alzheimers Dis 2022; 89:299-308. [DOI: 10.3233/jad-220173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Background: The Frontal Behavioral Inventory (FBI) is a questionnaire designed to quantify behavioral changes in frontotemporal dementia (FTD). Literature showed heterogeneous FBI profiles in FTD versus Alzheimer’s disease (AD) with variable occurrence of positive and negative symptoms. Objective: In this study, we constructed a short FBI version (i.e., mini-FBI) with the aim to provide clinicians with a short tool for the identification of early behavioral changes in behavioral variant of FTD (bvFTD), also facilitating the differential diagnosis with AD. Methods: 40 bvFTD and 33 AD patients were enrolled. FBI items were selected based on internal consistency and exploratory factor analysis. Convergent validity of mini-FBI was also assessed. A behavioral index (i.e., B-index) representing the balance between positive and negative mini-FBI symptoms was computed in order to analyze its distribution in bvFTD through a cluster analysis and to compare performance among patient groups. Results: The final version of the mini-FBI included 12 items, showing a significant convergent validity with the Neuropsychiatric Inventory scores (rp = 0.61, p < 0.001). Cluster analysis split patients in four clusters. bvFTD were included in three different clusters characterized by prevalent positive symptoms, both positive and negative symptoms, or prevalent negative behavioral alterations, similar to a subset of AD patients. A fourth cluster included only AD patients showing no positive symptoms. Conclusion: The mini-FBI is a valuable easily administrable questionnaire able to early identify symptoms effectively contributing to the bvFTD behavioral syndrome, aiding clinician in diagnosis and management.
Collapse
Affiliation(s)
- Chiara Cerami
- IUSS Cognitive Neuroscience ICoN Center, Scuola Universitaria Superiore IUSS Pavia, Pavia, Italy
- Cognitive Computational Neuroscience Research Unit, IRCCS Mondino Foundation, Pavia, Italy
| | - Elena Perdixi
- Department of Neurology, IRCCS Humanitas Clinical and Research Center, Rozzano, Milano, Italy
| | - Claudia Meli
- Center for Neurocognitive Rehabilitation - CIMeC, University of Trento, Rovereto (TN), Italy
| | - Alessandra Marcone
- Department of Rehabilitation and Functional Recovery, San Raffaele Hospital, Milan, Italy
| | - Michele Zamboni
- Department of Rehabilitation and Functional Recovery, San Raffaele Hospital, Milan, Italy
| | - Sandro Iannaccone
- Department of Rehabilitation and Functional Recovery, San Raffaele Hospital, Milan, Italy
| | - Alessandra Dodich
- Center for Neurocognitive Rehabilitation - CIMeC, University of Trento, Rovereto (TN), Italy
| |
Collapse
|
7
|
García AM, Ibáñez A, Miller B, Gorno Tempini ML. Editorial: The Unusual Suspects: Linguistic Deficits in Non-Language-Dominant Neurodegenerative Diseases. Front Aging Neurosci 2022; 14:861041. [PMID: 35250552 PMCID: PMC8888668 DOI: 10.3389/fnagi.2022.861041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Accepted: 01/25/2022] [Indexed: 11/13/2022] Open
Affiliation(s)
- Adolfo M. García
- Cognitive Neuroscience Center, Universidad de San Andrés, Buenos Aires, Argentina
- Global Brain Health Institute, University of California, San Francisco, San Francisco, CA, United States; and Trinity College Dublin, Dublin, Ireland
- National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina
- Departamento de Lingüística y Literatura, Facultad de Humanidades, Universidad de Santiago de Chile, Santiago, Chile
| | - Agustín Ibáñez
- Cognitive Neuroscience Center, Universidad de San Andrés, Buenos Aires, Argentina
- Global Brain Health Institute, University of California, San Francisco, San Francisco, CA, United States; and Trinity College Dublin, Dublin, Ireland
- National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina
- Latin American Brain Health Institute (BrainLat), Universidad Adolfo Ibáñez, Santiago, Chile
| | - Bruce Miller
- Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, United States
| | - Maria Luisa Gorno Tempini
- Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, United States
| |
Collapse
|